Gastrointestinal Disorder Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Disorder Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Disorder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Disorder Therapeutics Overall Market Size
2.1 Global Gastrointestinal Disorder Therapeutics Market Size: 2021 VS 2027
2.2 Global Gastrointestinal Disorder Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Disorder Therapeutics Players in Global Market
3.2 Top Global Gastrointestinal Disorder Therapeutics Companies Ranked by Revenue
3.3 Global Gastrointestinal Disorder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Disorder Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gastrointestinal Disorder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Disorder Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Disorder Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Disorder Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Disorder Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Irritable Bowel Syndrome (IBS)
4.1.3 Chronic Constipation (CC)
4.1.4 Ulcerative Colitis (UC)
4.2 By Type - Global Gastrointestinal Disorder Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Disorder Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Gastrointestinal Disorder Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Disorder Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Gastrointestinal Disorder Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Disorder Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Gastrointestinal Disorder Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gastrointestinal Disorder Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Gastrointestinal Disorder Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Disorder Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Gastrointestinal Disorder Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gastrointestinal Disorder Therapeutics Revenue, 2016-2027
6.3.2 US Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.3.3 Canada Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.3.4 Mexico Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Disorder Therapeutics Revenue, 2016-2027
6.4.2 Germany Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.3 France Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.4 U.K. Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.5 Italy Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.6 Russia Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.4.8 Benelux Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Disorder Therapeutics Revenue, 2016-2027
6.5.2 China Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.5.3 Japan Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.5.4 South Korea Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.5.6 India Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gastrointestinal Disorder Therapeutics Revenue, 2016-2027
6.6.2 Brazil Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.6.3 Argentina Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue, 2016-2027
6.7.2 Turkey Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.7.3 Israel Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
6.7.5 UAE Gastrointestinal Disorder Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Major Product Offerings
7.1.4 AstraZeneca Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.1.5 AstraZeneca Key News
7.2 Takeda Pharmaceutical
7.2.1 Takeda Pharmaceutical Corporate Summary
7.2.2 Takeda Pharmaceutical Business Overview
7.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Major Product Offerings
7.2.4 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.2.5 Takeda Pharmaceutical Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Major Product Offerings
7.3.4 Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 Eisai
7.4.1 Eisai Corporate Summary
7.4.2 Eisai Business Overview
7.4.3 Eisai Gastrointestinal Disorder Therapeutics Major Product Offerings
7.4.4 Eisai Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.4.5 Eisai Key News
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Corporate Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Major Product Offerings
7.5.4 Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.5.5 Abbott Laboratories Key News
7.6 Salix Pharmaceuticals
7.6.1 Salix Pharmaceuticals Corporate Summary
7.6.2 Salix Pharmaceuticals Business Overview
7.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Major Product Offerings
7.6.4 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.6.5 Salix Pharmaceuticals Key News
7.7 Bausch Health
7.7.1 Bausch Health Corporate Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Major Product Offerings
7.4.4 Bausch Health Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.7.5 Bausch Health Key News
7.8 Allergan
7.8.1 Allergan Corporate Summary
7.8.2 Allergan Business Overview
7.8.3 Allergan Gastrointestinal Disorder Therapeutics Major Product Offerings
7.8.4 Allergan Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.8.5 Allergan Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Gastrointestinal Disorder Therapeutics Major Product Offerings
7.9.4 Bayer Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.9.5 Bayer Key News
7.10 UCB
7.10.1 UCB Corporate Summary
7.10.2 UCB Business Overview
7.10.3 UCB Gastrointestinal Disorder Therapeutics Major Product Offerings
7.10.4 UCB Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.10.5 UCB Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Gastrointestinal Disorder Therapeutics Major Product Offerings
7.11.4 AbbVie Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.11.5 AbbVie Key News
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Corporate Summary
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Major Product Offerings
7.12.4 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.12.5 GlaxoSmithKline Key News
7.13 Astellas Pharma
7.13.1 Astellas Pharma Corporate Summary
7.13.2 Astellas Pharma Business Overview
7.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Major Product Offerings
7.13.4 Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue in Global (2016-2021)
7.13.5 Astellas Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Gastrointestinal Disorder Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Disorder Therapeutics Market Drivers in Global Market
Table 3. Gastrointestinal Disorder Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Disorder Therapeutics in Global Market
Table 5. Top Gastrointestinal Disorder Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gastrointestinal Disorder Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gastrointestinal Disorder Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gastrointestinal Disorder Therapeutics Product Type
Table 9. List of Global Tier 1 Gastrointestinal Disorder Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Disorder Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gastrointestinal Disorder Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gastrointestinal Disorder Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gastrointestinal Disorder Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gastrointestinal Disorder Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Gastrointestinal Disorder Therapeutics Product Offerings
Table 32. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Takeda Pharmaceutical Corporate Summary
Table 34. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Offerings
Table 35. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product Offerings
Table 38. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Eisai Corporate Summary
Table 40. Eisai Gastrointestinal Disorder Therapeutics Product Offerings
Table 41. Eisai Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Offerings
Table 44. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Salix Pharmaceuticals Corporate Summary
Table 46. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Offerings
Table 47. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Bausch Health Corporate Summary
Table 49. Bausch Health Gastrointestinal Disorder Therapeutics Product Offerings
Table 50. Bausch Health Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Allergan Corporate Summary
Table 52. Allergan Gastrointestinal Disorder Therapeutics Product Offerings
Table 53. Allergan Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Bayer Corporate Summary
Table 55. Bayer Gastrointestinal Disorder Therapeutics Product Offerings
Table 56. Bayer Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. UCB Corporate Summary
Table 58. UCB Gastrointestinal Disorder Therapeutics Product Offerings
Table 59. UCB Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Gastrointestinal Disorder Therapeutics Product Offerings
Table 62. AbbVie Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. GlaxoSmithKline Corporate Summary
Table 64. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Offerings
Table 65. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. Astellas Pharma Corporate Summary
Table 67. Astellas Pharma Gastrointestinal Disorder Therapeutics Product Offerings
Table 68. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Gastrointestinal Disorder Therapeutics Segment by Type
Figure 2. Gastrointestinal Disorder Therapeutics Segment by Application
Figure 3. Global Gastrointestinal Disorder Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Disorder Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gastrointestinal Disorder Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2020
Figure 8. By Type - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gastrointestinal Disorder Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Eisai Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bausch Health Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Allergan Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bayer Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. UCB Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. AbbVie Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma